Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
Melioidosis (infection caused by Burkholderia pseudomallei) requires a prolonged course of oral antibiotics following initial intravenous therapy to reduce the risk of relapse after cessation of treatment. The current recommendation is a four-drug regimen (trimethoprim [TMP], sulfamethoxazole [SMX],...
Main Authors: | Chaowagul, W, Chierakul, W, Simpson, A, Short, J, Stepniewska, K, Maharjan, B, Rajchanuvong, A, Busarawong, D, Limmathurotsakul, D, Cheng, A, Wuthiekanun, V, Newton, P, White, N, Day, N, Peacock, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
by: Chaowagul, W, et al.
Published: (1999) -
Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.
by: Chetchotisakd, P, et al.
Published: (2014) -
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
by: Cheng, A, et al.
Published: (2009) -
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
by: Wuthiekanun, V, et al.
Published: (2005) -
Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
by: Chierakul, W, et al.
Published: (2005)